Invasive lobular and ductal breast cancers: a systematic review and metanalysis in association with BRCA1/2 mutation status
- 25 March 2026
- journal article
- review article
- Published by Elsevier in European Journal of Cancer
- Vol. 239, 116692
Abstract
No abstract availableKeywords
Funding Information
- Fondazione Umberto Veronesi
- Foundation for the National Institutes of Health (P30CA008748)
- National Cancer Institute (P30CA008748)
- National Institutes of Health
- Ministero della Salute
This publication has 33 references indexed in Scilit:
- Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research groupCancer Treatment Reviews, 2025
- Tumor mutational burden status and clinical characteristics of invasive lobular carcinoma of the breastBreast Cancer, 2025
- Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histologyESMO Open, 2024
- CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer PhenotypeJAMA Network Open, 2024
- Genomic disparity impacts variant classification of cancer susceptibility genes in Turkish breast cancer patientsCancer Medicine, 2024
- Comprehensive Review of Molecular Mechanisms and Clinical Features of Invasive Lobular CancerThe Oncologist, 2021
- Response to neoadjuvant chemotherapy in ductal compared to lobular carcinoma of the breast: a meta-analysis of published trials including 1,764 lobular breast cancerBreast Cancer Research and Treatment, 2013
- Trends in Incidence Rates of Invasive Lobular and Ductal Breast CarcinomaJAMA, 2003
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Advanced methods in meta‐analysis: multivariate approach and meta‐regressionStatistics in Medicine, 2002